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Abstract 
Purpose: To isolate and evaluate the antimutagenic properties of compounds previously identified in 
octopus (Paraoctopus limaculatus). 
Methods: Octopus fractions, previously obtained by a sequential thin layer chromatography (TLC) 
procedure, were subjected to further fractionation by TLC and their anti-mutagenic activity monitored 
using Salmonella tester strains TA98 and TA100 with metabolic activation (S9) in Ames test. The 
isolated fractions were subjected to structural studies by Fourier transformed infrared spectroscopy (FT-
IR), nuclear magnetic resonance (1H and 13C NMR), and gas chromatography-mass spectrometry. 
Results: Five new fractions were obtained from a previously isolated and reported anti-mutagenic 
octopus fraction. Fractions RB21321b2 and RB21321b3 inhibited > 80 % of the mutagenicity induced by 
500 ng AFB1 on both tester strains and were selected for chemical/structural characterization. Data 
from IR and 1H and 13C NMR suggested the presence of phthalate type of compounds. GC-MS analysis 
revealed 278 m/z for both fractions which is consistent with a butyl isobutyl phthalate structure. 
Conclusion:  Based on the findings, the compound responsible for the high anti-mutagenic activity of 
the isolated fraction from octopus is 1-butyl-2-isobutyl-phthalate. 
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Covering > 70 % of the planet's surface, marine 
ecosystems comprise a continuous resource of 
immeasurable biological activities and immense 
chemical entities. Marine fauna and flora usually 
produce secondary metabolites with structural 
features distinct from other natural sources, 
which are of interest for potential industrial and 
medical applications [1,2]. One of the 
components of interest is the lipid fraction of 
marine organisms that have been associated 
with the prevention of chronic degenerative 
diseases such as cardiovascular diseases and 
cancer [3-7]. Unsaturated fatty acids ω-3 and ω-
6 isolated from different marine sources have 
been shown to be anti-mutagenic and anti-
carcinogenic [8].  
 
Recent studies have identified compounds with 
biological activity such as rhizochalin, an 
antimicrobial and cytotoxic marine two-headed 
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sphingolipid isolated from the sponge 
(Rhizochalina incrustata) [9]; alkylglycerols, from 
shark (Centrophorus squamosus) liver oil with 
anti-tumor and anti-metastasis activities [10]; 
sulfoglycolipid, from marine macroalgae 
(Porphyra crispata) which inhibited the growth of 
human hepatocellular carcinoma cell line HepG2 
[11]; and terpenoids, isolated from marine 
organisms and sponges which were found to 
exhibit anti-inflammatory, antimicrobial, and anti-
tumor activities [12]. In a previous research work 
[13], anti-mutagenic fractions were obtained from 
octopus and the chemical attributes of the 
bioactive compounds contained in these fractions 
were partially characterized. The aim of this 
research work was to identify the bioactive 
agents that were previously detected in octopus 
(Paraoctopus limaculatus) and were reported by 




Testing species  
 
Octopus (Paraoctopus limaculatus) was obtained 
from a local market in Hermosillo, Sonora, 
México, and transported in ice to the University 
of Sonora. Octopus tentacles were separated, 
packed, and stored at –20 °C until analysis.  
 
The extraction of the lipid fraction, carried out 
avoiding direct exposition to light, was performed 
according to the methodology reported by 
Burgos-Hernández et al [14] and Moreno-Felix et 
al [13]. A sample of 100 g of octopus muscle and 
five parts (w/v) of CHCl3 were homogenized in a 
blender at high speed for 1 min. The resulting 
homogenate was poured into a flask and agitated 
for 40 min in a Wrist Action Burrel Shaker (Burrel 
Corporation, Pittsburg, PA, U.S.). The mixture 
was filtered through a Whatman No. 1 filter paper 
under vacuum and the filtrate was evaporated to 
dryness. The extract was then re-dissolved in a 
chloroform-acetone solution (9:1 v/v). 
 
Fractionation of octopus extract  
 
The fractionation of octopus extract was 
performed according to the method of Burgos-
Hernandez et al [14]. A 2.0 mL aliquot of octopus 
muscle extract was applied on to a 3.0 mm thick 
silica gel-coated preparative TLC plate and 
developed with chloroform-acetone solution (9:1 
v/v). Fluorescent bands, identified by their Rf 
values, were scrapped off the plate and the 
contents of the silica were extracted with 2 × 25 
mL chloroform-methanol-acetone solution (9:1:1 
v/v/v). The extracts were re-suspended, serially 
diluted in dimethyl sulfoxide (DMSO) and tested 
for anti-mutagenicity. When anti-mutagenic 
bands were detected, their contents were again 
obtained from a fresh muscle sample following 
the same procedure and were subjected to 
further fractionation (Figure 1). 
 
 
Figure 1: Schematic for separation and isolation of anti-mutagenic fractions from octopus. Numbers in 
parenthesis are Rf values. *Obtained and previously reported by Moreno-Félix et al [13] 
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Bacterial cultures  
 
Salmonella typhimurium TA98 and TA100 tester 
strains were used. Fresh overnight tester axenic 
cultures were stored at –80 °C and routinely 
checked to confirm genetic characteristics using 
the procedure described by Maron and Ames 
[15].  
 
Antimutagenicity test  
 
The Ames test was used to test the anti-
mutagenic activity of the dry extracts obtained 
from preparative-thin layer chromatography 
(TLC) fractionation procedures. Extracts were 
reconstituted with dimethyl sulfoxide (DMSO) to 
a final concentration of 10 mg/mL, serially diluted 
(1:10 v/v) also with DMSO and spiked with pure 
aflatoxin AFB1 (AFB1) (Sigma-Aldrich, St. Louis, 
MO, U.S.) to a final concentration of 500 ng of 
AFB1/100 μL of diluted extract. Metabolic 
activation system S9 mix (Aroclor 1254-induced, 
Sprague-Dawley male rat liver in 0.154 M KCl 
solution, Molecular Toxicology, Inc.; Annapolis, 
MD, U.S.) was used to bioactivate AFB1. 
Residual mutagenicity of AFB1 was assayed 
using the standard plate incorporation procedure 
described by Maron and Ames (1983). Different 
AFB1 concentrations, including 500 ng AFB1/100 
μL, were used as controls for both tester strains. 
All assays were performed in triplicate.  
 
Structural studies  
 
Chemical characterization of the compounds 
isolated from octopus bioactive fractions was 
performed through Fourier Transformed Infrared 
(FT-IR), nuclear magnetic resonance (1H and 13C 
NMR), and mass spectrometry analyses. 
Compounds were dissolved in HPLC-grade 
acetone before the analysis. The FT-IR spectrum 
was obtained using the GX Perkin Elmer 
equipment. The percentage transmittance was 
measured against the wave number from 4000 to 
400 cm-1. NMR spectroscopy was performed for 
the compound dissolved in deuterated 
chloroform (CDCl3), and the spectra were 
recorded on a Bruker Avance 400 MHz using 
tetramethylsilane (TMS) as a reference. The 
mass spectrum was obtained with a VARIAN 
431-GC gas chromatograph equipped with a 
VARIAN 210-MS ion trap mass detector. 
Chromatographic separation was achieved using 
a capillary column Factor Four TM VF-5ms (30 m 
x 0.25 mm x 0.25 μm) purchased from VARIAN 
and ultra-high purity helium was used as carrier 
gas at a constant flow of 13 mL/min, in splitless 
injection mode. Samples were dissolved in 
HPLC-grade chloroform and a 3.0 μL aliquot was 
injected. An initial oven temperature of 120 °C 
was held for 5 min, followed by a ramp of 10 
°C/min to 180 °C, holding for 30 min, followed by 
a ramp of 10 °C/min to 210 °C, holding for 20 
min. The injection port temperature was 
maintained at 250 °C. Total chromatographic 
separation was achieved in 64 min. The transfer 
line, manifold, and trap temperatures were 205, 
80 and 150 °C, respectively. All mass spectra 
were acquired in the electron impact mode. 
Ionization was not applied during the first 2 min, 
to avoid solvent overloading. The scan was 
performed from 40 to 500 m/z with a scan rate of 
1 scan/s. 
 
Statistical analysis  
 
Data were analyzed using analysis of variance 
(ANOVA) with Tukey-Kramer test (p < 0.05) with 
the aid of JMP statistical software (Visual 






Contents from band RB21321 resulted from the 
sixth TLC fractionation step of octopus muscle 
were used for further fractionation in the present 
study, due to the higher inhibition exerted on the 
mutagenicity of AFB1 and shown in a dose-
response type of relationship. The subsequent 
fractionation carried out to finally isolate the 
bioactive compounds is shown in Figure 1. 
 
After TLC fractionation step 7, an additional band 
was obtained and coded as RB21321b. The 
contents from this band were extracted and 
subjected to a TLC fractionation step 8, from 
which four bands were observed (RB21321b1, 
RB21321b2, RB21321b3 and RB21321b4). The 
anti-mutagenic activity of all fractions obtained 
from TLC fractionation procedures 7 and 8 
(RB21321a1, RB21321b1, RB21321b2, 
RB21321b3 and RB21321b4) was evaluated. 
Anti-mutagenicity results showed that all 
fractions have inhibitory effects on the 
mutagenicity of 500 ng of AFB1 in both tester 
strains, the fraction RB21321a1 (Table 1) 
inhibited the mutagenicity of AFB1 in > 85 and 61 
% for TA98 and TA100 tester strains, 
respectively. 
 
Fraction RB21321b1 decreased the reversion 
rate achieved by 500 ng of AFB1 in a 78 % for 
TA98 and 62 % for TA100. The Ames test 
showed that RB21321b2 fraction inhibited the 
mutagenicity of AFB1 in > 84 % for both strains 
and a similar behavior was observed in fraction 
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RB21321b3, where the inhibition of the induced-
mutagenic potential of AFB1 was 83 % for TA98 
and 80 % for TA100.  
 
These results suggest that anti-mutagenic 
compounds were contained in both samples; 
therefore, RB21321b2 and RB21321b3 fractions 
were selected for chemical characterization. 
Finally, fraction RB21321b4 showed a dose-
response type of relationships that failed to be 
consistent in both tester strains, as those 




Fractions with higher antimutagenic potential 
(RB21321b2 and RB21321b3) were 
characterized by FT-IR, 1H and 13C NMR 
spectroscopy, and mass spectrometry. In all 
cases the spectroscopic data were consistent 
with the proposed structure. The Fourier 
Transform Infrared Spectrum (FT-IR) of the 
fraction RB21321b2 (Figure 2) showed one band 
at 2959 cm-1 associated to C-H stretching of a 
CH3 group. A sharp and strong band at 1729 cm-
1 confirmed the presence of the carbonyl group, 
while the band localized at 1272 cm-1 is 
associated to the flexion of C-O group present in 
ester bonds [16]. Fraction RB21321b3 showed a 
similar FT-IR spectrum than RB21321b2. The C-
H stretch vibrations observed at 2958 cm-1 are 
attributed to methylene groups. Furthermore, the 
presence of the ester group was evident due to 
both, the stretching and flexion signals detected 
at 1729 and 1272 cm-1, respectively, which is 
associated to C-O bonds. 
 
The analysis of the 1H NMR spectrum (400 MHz) 
(Figure 3a and 3b) showed two signals at low 
field: between δ = 7.51 -7.54 and δ = 7.69 -7.72 
ppm. These signals are evidence of hydrogen 
characteristically attached to an aromatic ring. A 
signal at δ = 4.18- 4.32 ppm may be attributed to 
the protons of an adjacent carbon attached to 
oxygen present in an ester bond (C-O). Finally, 
chemical shifts at high field δ = 0.88 -1.71 ppm 
can be attributed to methyl, methylene, and 
methine protons. The signals displayed by the 1H 
NMR spectrum are consistent with the 13C NMR 
spectrum for both fractions. The 13C NMR 
spectrum showed a typical signal for carbonyl 
function group at δ = 167.7 ppm (Figure 3c and 
3d), which is a characteristic value for carbons in 
an ester carbonyl group; additionally, the signal 
observed at δ = 68 ppm is associated to a 
carbon from a C-O bond. The signals observed 
between 128 ppm and 132 ppm, which are 
common for aromatic ring carbons; suggest the 
presence of a compound with an aromatic 
portion in its structure. Signals between 10 ppm 
and 38 ppm are characteristics for aliphatic chain 
carbons. 
 
Table 1: Anti-mutagenic potential of AFB1a spiked fractions obtained after thin layer chromatography fractionation 
step TLC 8 applied to fractions RB21321a (Rf = 0.84 – 0.92) and RB21321b (Rf = 0.92 – 1.0) (averageb TA100 
and TA98 revertants/plate, with S9) 
 
Extract fractionc Fraction dilutionc 
1 x 100 1 x 10-1 1 x 10-2 1 x 10-3 
TA98     
RB21321a1 123  20c 261  14b 442  6a 728  60a 
RB21321b1 182  19b 301  86b 470  19a 572  14bc 
RB21321b2 97  16c 297  58b 491  80a 548  28c 
RB21321b3 143  15bc 340  22ab 511  89a 647  33ab 
RB21321b4 442  16a 449  21a 496  17a 580  22bc 
TA100     
RB21321a1 512  99a 654  17a 739  47a 1217  121a 
RB21321b1 498  10a 536  22b 762  123a 840  29b 
RB21321b2 209  8c 506  41bc 740  25a 849  21b 
RB21321b3 270  8bc 461  3c 505  73b 661  88b 
RB21321b4 330  24b 515  33bc 614  18ab 766  23b 
aAFB1 (used as positive control) tested at 500 ng/plate induced 838 ± 52 and 1326 ± 54 revertants/plate for TA98 
and TA100, respectively. Spontaneous revertants were 23 ± 10 and 146 ± 17 for TA98 and TA100, respectively. 
bValues are means of three replicates ± standard error mean. Different letters within both, columns and bacterial 
strain, represent significant differences (p < 0.05). cExtracts were diluted and spiked with enough toxin to yield 
500 ng of pure AFB1/plate 
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Figure 3: 1H-NMR (a and b) and 13C-NMR (c and d) (CDCl3/TMS) spectra of RB21321b2 (a and c) and 
RB21321b3 (b and d) antimutagenic fractions obtained from octopus lipidic extract 
 
Chromatographic analyses of RB21321b2 
fraction revealed the presence of two major 
compounds with retention times of 22.37 min 
(peak 1) and with 28.40 min (peak 2), both 
represent 80 % of the signals (Figure 4a). The 
mass spectrum of peak 2 showed a (M+H)+ peak 
at 278 m/z, which suggest the following 
condensed molecular formula C16H22O4. Anti-
mutagenic fraction RB21321b3 represents > 64 
% of the signals, consisting of only one peak with 
a retention time of 28.28 min and (M+H)+ peak at 
278 m/z (Figure 4b). For both fractions, the mass 
spectral data suggested a molecule containing 
an aromatic ring with an aliphatic chain attached 
through an ester bond. These characteristics 
coincide with results obtained from 1H RMN and 
13C RMN analyses. Based on the above, a 
chemical structure similar to butyl isobutyl 
phthalate is proposed for the anti-mutagenic 
compound present in both fractions. The 
difference between RB21321b2 and RB21321b3 
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might be due to specific structural difference in 
isomeric nature. 
 
Subsequent fractionation of RB21321 resulted in 
two bands coded RB21321a and RB21321b, 
which were subjected to a further fractionation; 
RB21321a did not separate, while RB21321b 
fractionated in four different regions 
(RB21321b1, RB21321b2, RB21321b3, and 
RB21321b4). 
 
Fractions RB21321b2 and RB21321b3 showed 
anti-mutagenic potential since they caused the 
highest inhibition of AFB1 mutagenicity, showing 
a dose-response type of relationship and 
lowering the reversion rate to the spontaneous 
reversion level when these fractions were 
undiluted. These results suggest the presence of 
compounds with similar anti-mutagenic 
characteristics.  
 
Recently, research work has also reported the 
presence of bioactive compounds from the lipidic 
fraction of marine organisms. Methanol and 
chloroform extracts, obtained from Sphyrna 
lewini, induced evident decrease in the 
mutagenicity of an indirect acting mutagen [17]. 
Antimutagenic and antiproliferative studies of 
lipid extracts from white shrimp suggested 
chemoprotective properties since reduced the 
mutagenicity of AFB1 and proliferation of a 
cancer cell line M12.C3.F6 [18]. According to 
results obtained from mass spectrometry data 
base (Figure 4a and 4b), the isolated 





Bioactive phthalate derivatives have been 
isolated from various natural sources. Di(2- 
ethylhexyl) phthalate was isolated as a major 
bioactive metabolite of a newly isolated soil 
streptomyces (Streptomyces mirabilis strain 
NSQu-25). El-Sayed [19] found this compound to 
have antimicrobial activity against Gram-positive 
bacteria and yeasts, and also highly cytotoxic for 
human colon and human breast carcinoma cells. 
The presence of bioactive phthalate in several 
natural sources is consistent with our findings.  
 
Lee et al [20] isolated di(2-ethylhexyl) phthalate 
from Aloe vera Linnen. They found this phthalate 
derivative to have anti-leukemic and anti-
mutagenic properties as assayed in human 
tumor cell lines and Salmonella typhimurium 




Figure 4: GC-MS spectra of antimutagenic fractions RB21321b2 (a) and RB21321b3 (b) obtained from octopus 
lipidic fraction 
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Inhibition of α-glucosidase has been reported for 
butyl-isobutyl-phthalate, which was isolated from 
Laminaria japonica rhizoid, considering this 
phthalate derivative as an important anti-diabetes 
agent for type II diabetes therapy [21].  
 
However, latest studies have reported the 
presence of bioactive phthalate derivatives in 
various marine species, which is consistent with 
finding from the present research work. Potent 
antioxidant phthalate derivatives 2-ethyldecyl 2- 
ethylundecyl phthalate, 2, 12-diethyl-11-
methylhexadecyl 2-ethyl-11-
methylhexadecylphthalate, and Bis (2-
ethylheptyl) phthalate have been isolated from 
Hippocampus kuda [22]. Moreover, bis (2-
ethylhexyl) phthalate, isolated from marine 
bacteria Bacillus pumilus MB 40, was found to be 
an apoptosis inducer in leukemic K562 cells, 
activating caspases, promoting the releasing of 
cytochrome c from mitochondria and decreasing 
Bcl-2 level [23]. This compound was also 
capable of arresting cell cycle at sub G0/G1 
phase. Also, di-isobutyl phthalate and di-n-butyl 
phthalate, and bis-[2-ethyl]-hexyl-phthylester 
have been recently isolated from marine sponges 
Smenospongia and Niphates, respectively [24].  
 
Authors reported that all three phthalate 
derivatives exhibited several inhibitory effects on 
oxidative stress parameters, as well as inhibitory 
effects on the activity of carbohydrate 
hydrolyzing enzymes. More recently in our 
laboratory, we have reported the isolation of an 
anti-proliferative phthalate derivative from white 
shrimp (Litopenaeus vannamei), which was 
identified as di-ethyl-hexyl-phthalate [25]. This 
compound caused 50 % inhibition of murine 
M12. C3F6 transformed cell line growth at a 
concentration of 50 µg/mL. Even though 
phthalates have been reported as marine 
environmental contaminants [26-28], the 
existence of various derivative forms of this type 
of compounds might also suggest 
biotransformation processes that marine 
organism may perform on phthalates converting 
them into bioactive compounds that might be of 
interest for the biomedical industry. 
 
Based on the above and from results from the 
present research work, there are evidence 
supporting that 1-butyl-2-isobutyl-phthalate, 
isolated from octopus fraction, is the compound 
responsible for their anti-mutagenic activity; 
however, further investigation is necessary to 
fully assess its potential as a biomedical 
approach. Based on the literature, this is the first 
report on the identification of an anti-mutagenic 




Fractions RB21321a and RB21321b (CCF7) 
obtained from octopus (Paraoctopus limaculatus) 
contain at least 5 lipid fractions. RB21321b2 and 
RB21321b3 fractions have anti-mutagenic 
potential with a high percentage of inhibition of 
AFB1 for Salmonella typhimurium tester strains 
TA98 and TA100. Based on the findings from this 
study, the anti-mutagenic compound present in 
both fractions is a 1-butyl-2-isobutyl-phthalate 
derivative. However, further studies need to be 
carried out to determine differences due to 
possible isomerism. Further work should also 
focus on the development of new anti-cancer 
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